NNVC Company Profile and Key Details
NanoViricides, Inc.
NNVC Stock Price Chart
Stock Price Today
NanoViricides, Inc. (NNVC) stock surged +15.75%, trading at $1.32 on AMEX, up from the previous close of $1.14. The stock opened at $1.24, fluctuating between $1.24 and $1.34 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
NanoViricides, Inc., a nano-biopharmaceutical research and development company, discovers, develops, and commercializes drugs for the treatment of viral infections. The company develops Human Coronavirus Program for COVID-19 seasonal coronavirus affliction; HerpeCide Dermal Topical and Eye Drops for the treatment of shingles, PHN, chickenpox, herpes, recurrent herpes labialis, genital herpes, and ocular herpes keratitis; and HerpeCide IntraOcular Injection for viral acute retinal necrosis The company also develops FluCide Broad-Spectrum Anti-Influenza nanoviricide, which is injectable for hospitalized patients and oral for outpatients; Nanoviricide eye drops for viral diseases of the external eye; DengueCide for treatment of various types of Dengue viruses; and HIVCide, an escape-resistant anti-HIV nanoviricide. In addition, it develops other nanoviricides drug projects for treatment of different viruses and indications; and HerpeCide program expansion drug projects for different herpes viruses for different indications. NanoViricides, Inc. was founded in 2005 and is based in Shelton, Connecticut.
Company Information
| Employees | 7 |
| Beta | 0.97 |
| Sales or Revenue | $0.00 |
| 5Y Sales Change% | 0% |
| Fiscal Year Ends | June |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
NanoViricides, Inc. (AMEX: NNVC) stock price is $1.32 in the last trading session. During the trading session, NNVC stock reached the peak price of $1.34 while $1.24 was the lowest point it dropped to. The percentage change in NNVC stock occurred in the recent session was 15.75% while the dollar amount for the price change in NNVC stock was $0.18.
The AMEX listed NNVC is part of Biotechnology industry that operates in the broader Healthcare sector. NanoViricides, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Dr. Anil R. Diwan Ph.D.
Executive Chairman, Pres, Chief Executive Officer & Sec.
Ms. Meeta R. Vyas B.S., M.B.A., SB, MBA
Chief Financial Officer
Dr. Randall W. Barton Ph.D.
Chief Scientific Officer & Chief Regulatory Officer
NNVC's closing price is 10.68% higher than its 52-week low of $1.03 where as its distance from 52-week high of $3.59 is -68.25%.
Number of NNVC employees currently stands at 7.
Official Website of NNVC is: https://www.nanoviricides.com
NNVC could be contacted at phone 203 937 6137 and can also be accessed through its website. NNVC operates from 1 Controls Drive, Shelton, CT 06484, United States.
NNVC stock volume for the day was 836.84K shares. The average number of NNVC shares traded daily for last 3 months was 325.25K.
The market value of NNVC currently stands at $18.93M with its latest stock price at $1.32 and 14.35M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com